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Purpose: Congenital cataracts are one of the most treatable causes of visual impairment and blindness during infancy.
Approximately 50% of all congenital cataract cases may have a genetic cause. Once there is an intimate relationship
between crystallin genes and lens transparency, they are excellent candidate genes for inherited cataract. The purpose of
this study was to investigate mutations in αA-crystallin (CRYAA), γC-crystallin (CRYGC), and γD-crystallin (CRYGD) in
Brazilian families with nuclear and lamellar autosomal dominant congenital cataract.
Methods: Eleven Brazilian families were referred to the Santa Casa de São Paulo Ophthalmology Department. The coding
regions and intron/exon boundaries of CRYAA, CRYGC, and CRYGD were amplified by polymerase chain reaction (PCR)
and directly sequenced. Mutation screening was performed in the control group by restriction digestion.
Results: Two mutations were observed in different families (Family 4 and Family 10), one is a new mutation (Y56X) in
CRYGD and the other a previously reported mutation (R12C) in CRYAA that is correlated with a different phenotype.
Genetic analysis revealed previously described polymorphisms in CRYAA (D2D) and CRYGD (Y17Y and R95R). A new
polymorphism in CRYGC (S119S) was identified only in Family 1. The mutations as well as the new polymorphism were
not observed in the control group.
Conclusions: In conclusion, we report a novel nonsense mutation (Y56X) in CRYGD and a previously reported missense
mutation (R12C) in CRYAA associated with nuclear cataract in Brazilian families. Both tyrosine in amino acid 56 in
CRYGD and arginine in amino acid 12 in CRYAA have been highly conserved throughout evolution in different species.
A new polymorphism (S119S) in CRYGC was also observed in one family. The analysis of nine families excluded possible
mutations in the crystallin genes, suggesting that other genes could be involved with congenital cataract.
Congenital  cataract  is  the  leading  cause  of  reversible
blindness  in  childhood.  Its  occurrence,  depending  on  the
regional socioeconomic development, is 1−6 cases per 10,000
live  births  in  industrialized  countries  [1,2]  and  5−15  per
10,000 in the poorest areas of the world [3,4]. Congenital
cataract is visible at birth or during the first decade of life
[5]. About 20,000−40,000 new cases of bilateral congenital
cataract are diagnosed each year [3,6]. In Brazil, congenital
cataract accounts for 12.8% of cases of blindness in childhood
[7]  due  to  different  causes  including  metabolic  disorders
(galactosemia) [8], infections during embryogenesis [1], gene
defects, and chromosomal abnormalities [9,10]. Cataract may
be an isolated anomaly or part of a multisystem syndrome such
as  Down  syndrome,  Wilson’s  disease,  and  myotonic
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dystrophy [11]. Inherited cataracts correspond to 8%−25% of
congenital cataracts [12]. Although X-linked and autosomal
recessive transmission has been observed, the most frequent
mode of inheritance is autosomal dominant with a high degree
of penetrance [13,14]. Inherited cataracts are clinically highly
heterogeneous  and  show  considerable  interfamilial  and
intrafamilial variability [15].
Congenital cataracts are also genetically heterogeneous
[14]. It is known that different mutations in the same gene can
cause  similar  cataract  patterns  while  the  highly  variable
morphologies of cataracts within some families suggest that
the  same  mutation  in  a  single  gene  can  lead  to  different
phenotypes [15,16]. To date, more than 25 loci and genes on
different chromosomes have been associated with congenital
cataract [17]. Mutations in distinct genes that encode the main
cytoplasmic proteins of human lens have been associated with
cataracts  of  various  morphologies  [18]  including  genes
encoding  crystallins  (CRYA,CRYB,  and  CRYG)  [19],  lens
specific connexins (Cx43,Cx46, and Cx50) [20,21], aquaporin
(MIP) [22], cytoskeletal structural proteins (beaded filament
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793structural protein 2 [BFSP2]) [23], paired-like homeodomain
3  (PITX3)  [24],  avian  musculoaponeurotic  fibrosarcoma
(MAF)  [25],  and  heat  shock  transcription  factor  4  gene
(HSF4) [26]. Crystallin proteins (α-, β-, and γ-crystallins)
represent more than 90% of lens soluble proteins in humans,
encompassing almost 35% of its mass and accounting for its
optical transparency and high refractive index [6,13].
Mutations  in  the  crystallin  genes  represent  a  large
proportion of the mutations identified to date. These genes
may  be  divided  into  two  distinct  evolutionary  groups
comprising α-crystallins, which are members of the small heat
shock  family  of  molecular  chaperones  [27],  and  β/γ-
crystallins,  which  share  a  common  two  domain  structure
composed of Greek-key motifs and belong to the family of
epidermis specific differentiation proteins [28].
Lamellar and nuclear congenital cataracts are the most
common  types  of  hereditary  congenital  cataract  [29,30].
Several genes have been associated with the presence of these
two  types  of  cataracts  (CRYAA,CRYBA3/
A1,CRYGC,CRYGD,CRYGS,  connexin  46  [GJA3],  and
connexin  50  [GJA8])  [13,18,31].  In  this  study,  CRYAA,
CRYGC,  and  CRYGD  were  considered  as  candidates  for
congenital cataract on the basis of both their high levels of
expression in the lens and their known function in maintaining
lens transparency. Eleven Brazilian families with autosomal
dominant  nuclear  or  lamellar  congenital  cataracts  were
screened for mutations in CRYAA, CRYGC, and CRYGD.
METHODS
The study protocols adhered to the tenets of the Declaration
of Helsinki and were approved by the Human Research Ethics
Committees  of  the  Santa  Casa  de  São  Paulo  School  of
Medicine (São Paulo, Brazil).
Patients  and  control  group:  Families  with  a  positive
history of autosomal dominant bilateral nuclear or lamellar
cataract  were  investigated  at  Santa  Casa  de  São  Paulo
Ophthalmology Department. Both affected and unaffected
individuals  underwent  detailed  ophthalmic  examination
including Snellen visual acuity and corrected visual acuity in
addition to slit-lamp and fundus examination with dilated
pupil,  intraocular  pressure  measurement  by  applanation
tonometry, and corneal diameter. Detailed ocular, medical,
and family histories were obtained from each available family
member. Probands with a history suggestive of an intrauterine
infection such as rubella, unilateral cataract, and other ocular
or systemic disorders were excluded from the study. There
was no evidence of systemic abnormalities associated with
congenital cataract in the probands. After informed consent
was obtained from all participating individuals, 5–10 ml of
venous blood was collected for genomic DNA extraction and
subsequent molecular genetic analysis. Possible mutations
and new polymorphisms were analyzed by restriction enzyme
digestion in the control group, which was comprised by 50
ophthalmologically normal, unrelated Brazilian individuals
from Santa Casa de São Paulo Ophthalmology Department
with  the  same  ethnic  background  and  from  the  same
geographic region of the affected group.
Polymerase  chain  reaction  and  DNA  sequencing:
Polymerase chain reaction (PCR) was used to amplify all the
exons  and  intron/exon  boundaries  of  the  candidate  genes
(CRYAA, CRYGC, and CRYGD). Conditions are described as
follows: a 25 μl reaction volume included approximately 100
ng of genomic DNA, 20 pmol of each primer, 1X enzyme
buffer (10X buffer=20mM Tris-HCl [pH 8,4] 50 mM KCl,
0,01% gelatin), 1.5 mM MgCl2, 200 μM nucleotides (dATP,
dCTP,  dTTP,  dGTP),  0.5  U  of  Taq  DNA  polymerase
(Invitrogen™ Life Technologies, Carlsbad, CA), and sterile
deionized water. Samples were amplified on the MasterCycler
EP  Gradient  S  thermal  cycler  (Eppendorf,  Hamburg,
Germany)  according  to  the  following  conditions:  initial
denaturation at 94 °C for 5 min followed by 35 cycles of 94 °C
for 1 min, X °C for 1 min, 72 °C for 1 min, and final extension
at 72 °C for 7 min. Oligonucleotide primer pairs, PCR product
sizes, and annealing temperatures are described in Table 1.
Only  the  proband  of  each  family  has  been  screened  for
mutations in the candidate genes.
PCR products were electrophoresed in 1.5% agarose gels
containing 0.05% ethidium bromide, purified, and submitted
to direct sequencing on the ABI PRISM 310 Genetic Analyzer
automated sequencer (Applied Biosystems, Foster City, CA).
The sequencing reactions were performed under the following
conditions: 25 cycles of 96 °C for 10 s, 56 °C for 5 s, and 60 °C
for 4 min, using Big Dye Terminator Ready Reaction v3.1
(ABI PRISM Big Dye Terminator Cycle Sequencing Kit;
Applied  Biosystems).  Sequencing  results  were  analyzed
through submission to similarity search using the “search
algorithm” BLAST. Any sequence variation suggestive of a
mutation  was  later  confirmed  in  parents  and  available
relatives to determine the segregation with the disease.
Restriction digestion: Genetic variations were evaluated
in the control group by the presence/absence of cleavage sites
for  the  restriction  enzymes  HhaI  for  CRYAA,  MslI  for
CRYGC,  and  RsaI  for  CRYGD  (New  England  BioLabs,
Ipswith, MA). Digestions were conducted in accordance with
the  manufacturer’s  protocols.  The  resulting  restriction
fragments were separated in 2% agarose gels stained with
ethidium bromide and analyzed under ultraviolet (UV) light.
Computational  methods:  Besides  the  analysis  of  the
control group, computational algorithms were used to predict
which  variants  were  deleterious  and  which  were  neutral.
Three methods were used to determine if a specific amino acid
substitution within a protein sequence might lead to altered
protein  function  and  possibly  contribute  to  the  disease.
Automated  methods  available  on  the  Internet  were  used:
Sorting  Intolerant  from  Tolerant  amino  acid  substitutions
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Grantham score difference (Align-GVGD).
SIFT uses an evolutionary approach and is based on the
assumption that important amino acids tend to be conserved
across species. SIFT assigns a substitution probability from 0
to 1 for each possible amino acid change. Substitution with
probabilities less than 0.05 are considered intolerant (i.e.,
functionally significant) whereas those greater than or equal
to 0.05 are inferred as tolerated substitutions. PolyPhen takes
into account not only the evolutionary conservation of the
amino acid subjected to the mutation but also the physico-
chemical characteristics of the wild type and mutated amino
acid residue and the consequence of the amino acid change
for the structural properties of the protein. Align-GVGD is
based on chemical differences between each amino acid pair,
polarity, and molecular volume. The matrix of scores varies
from a minimum of 15 to a maximum of 215. Deleterious
mutations tend to have scores greater than 100 and tolerated
variations scores less than 60 [32,33].
RESULTS
Eleven families with autosomal dominant childhood cataracts
were identified, seven families presenting with the nuclear
phenotype  and  the  remaining  families  with  the  lamellar
phenotype (Table 2). A total of 34 affected members and 44
unaffected members were evaluated in this study.
The degree of opacification of lamellar cataracts showed
some variability among families. Families 6 and 11 presented
with lamellar cataracts significantly less dense than those in
Families 2 and 5.
Mutations were observed in two families (18.2%). In nine
families, no mutation in CRYAA, CRYGC, and CRYGD was
detected.  The  cataract  phenotypes  in  families  without
mutations  were  bilateral  nuclear  cataract  since  birth  in
affected members from Families 1, 3, 7, 8, and 9 and bilateral
lamellar in affected members from Families 2, 5, 6, and 11.
The proband of Family 8 who is of consanguineous origin
presented  with  nuclear  cataract  and  microcornea  like  the
affected father and mother. The father had retinal detachment
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TABLE 1. OLIGONUCLEOTIDES USED AS PRIMERS FOR PCR AMPLIFICATION OF THE CRYAA, CRYGC, AND CRYGD, PRODUCT SIZES, AND
ANNEALING TEMPERATURES.
Gene Exon Strand Sequence (5′→3′)
Product Size
(bp)
  T
(°C)
CRYAA 1 Sense CACGCCTTTCCAGAGAAATC 466 59
    Antisense CTCTGCAAGGGGATGAAGTG
  2 Sense CTTGGTGTGTGGGAGAAGAGG 377 57
    Antisense TCCCTCTCCCAGGGTTGAAG
  3 Sense CCCCCTTCTGCAGTCAGT 989 66
    Antisense GCTTGAGCTCAGGAGAAGGA
CRYGC 1–2 Sense ACCAGAGAACAAGGACACAATC 674 62
    Antisense TGGCTTATTCAGGTCTCTGATG
  3 Sense ATTCCATGCCACAACCTACC 590 62
    Antisense CCAACGTCTGAGGCTTGTTC
CRYGD 1–2 Sense CCCTTTTGTGCGGTTCTTG 596 58
    Antisense TTTGTCCACTCTCAGTTATTGTGAC
  3 Sense TGTGCTCGGTAATGAGGAG 700 62
    Antisense AGGCCAGAGAATCAAATGAG
TABLE 2. CATARACT PHENOTYPES, MUTATIONS, AND POLYMORPHISMS IDENTIFIED IN THIS STUDY.
                                             Mutation                                                  Polymorphism
CRYAA CRYGC CRYGD CRYAA CRYGC                      CRYGD
Family 1 Nuclear+Microcornea       D2D S119S Y17Y, R95R
Family 2 Lamellar       D2D   R95R
Family 3 Nuclear       D2D   Y17Y, R95R
Family 4 Nuclear R12C     D2D   R95R
Family 5 Lamellar       D2D   R95R
Family 6 Lamellar           Y17Y, R95R
Family 7 Nuclear       D2D   Y17Y, R95R
Family 8 Nuclear+Microcornea       D2D   Y17Y, R95R
Family 9 Nuclear       D2D  
Family 10 Nuclear     Y56X D2D   Y17Y, R95R
Family 11 Lamellar       D2D   Y17Y
Family ID  Cataract phenotypein  both  eyes  after  cataract  surgery  and  the  mother
postoperative glaucoma. In Family 1, all affected members
also  had  nuclear  opacity  and  microcornea.  This  family
comprised of 8 affected and 24 unaffected members spanning
four generations. The visual acuity of the proband was 20/40
in both eyes after cataract surgery. Nystagmus was present in
some families and absent in others, depending primarily on
the degree of visual impairment during the first months of life.
Mutations in CRYAA, CRYGC, and CRYGD associated
with human cataract: In 2 of the 11 probands (from Families
4 and 10), unique mutations in one of the three genes were
identified cosegregating in a heterozygous condition with the
disease in the each family. In both families, the congenital
bilateral  nuclear  cataract  was  present  in  all  affected
individuals.
Family  4  comprised  of  two  generations  with  three
affected members and one unaffected member (Figure 1).
Visual  acuity  of  the  affected  eyes  ranged  from  20/80  to
counting fingers after cataract surgery. In all cases, there was
amblyopia. The congenital bilateral nuclear cataract in this
family  is  associated  with  a  mutation  in  CRYAA,  a  point
mutation  in  exon  1  (CGC>TGC),  which  leads  to  the
replacement  of  an  arginine  at  position  12  for  a  cysteine
(R12C). This mutation was observed in all affected members
(I-2, II-1, and II-2) and was not observed in the unaffected
member  (I-1).  There  was  no  evidence  of  other  ocular  or
systemic abnormalities. This substitution resulted in the loss
of a HhaI restriction site. Wild type control PCR products were
digested into fragments of 286 bp, 96 bp, and 84 bp while the
presence  of  the  R12C  mutation  resulted  in  an  undigested
fragment of 382 bp as well as a common 84 bp fragment.
Restriction digestion of 50 normal controls did not detect the
mutation.
Computational program analysis of the R12C mutation
revealed the following results: in the PolyPhen the score was
2.664, which means with high confidence that this variant is
predicted to be “probably damaging.” Align-GVGD showed
a score of 179.53 when “deleterious” mutations tend to have
scores greater than 100. Finally, the SIFT method revealed a
score of 0.00 to position R12. Positions with a probability less
than 0.05 are predicted to be intolerant.
The proband of Family 10 was diagnosed with congenital
nuclear  cataract.  DNA  sequencing  analysis  of  CRYGD
showed  a  novel  heterozygous  nonsense  mutation
(TAC>TAG) within the second exon (Figure 2). Cataract was
most likely caused by this point mutation that leads to the
replacement  of  a  tyrosine  by  a  premature  stop  codon  at
position  56  (Y56X).This  mutation  was  observed  in  the
proband (II-1), her affected father (I-1), and affected brother
(II-2). The unaffected mother and the unaffected other brother
did  not  show  this  mutation.  On  clinical  examination,  the
affected members achieved a visual acuity of 20/40 in both
eyes (I-1, II-2) as well as 20/50 and counting fingers in the
right eye and left eye, respectively, of the proband. No other
ocular findings were observed. This transition resulted in the
loss of an RsaI restriction site, generating fragments of 396
bp, 108 bp, and 92 bp for the wild type allele and fragments
of 488 bp, 396 bp, 108 bp, and 92 bp for the mutant allele. The
analysis of 50 normal controls did not detect the substitution.
Polymorphisms in CRYAA, CRYGC, and CRYGD : A
variety of sequence variations referred as single nucleotide
polymorphisms  (SNPs)  was  observed  in  the  probands  for
CRYAA,  CRYGC,  and  CRYGD.  None  of  these  sequence
changes in the coding regions led to amino acid alterations.
Three known polymorphisms [34-36] were observed in the
sequencing  analysis,  D2D  (rs872331)  polymorphism
(GAC>GAT) in CRYAA (exon 1), which was observed in 10
probands; Y17Y (rs2242074) polymorphism (TAT>TAC) in
CRYGD (exon 2), which was observed in seven probands; and
R95R (rs2305430) polymorphism (AGA>AGG) in CRYGD
(exon  3),  which  was  observed  in  nine  probands.  A  new
polymorphism  in  the  third  exon  of  CRYGC  (S119S)  was
observed in Family 1. This alteration (AGC>AGT) resulted
in  the  gain  of  a  novel  MslI  restriction  site,  producing
fragments of 387 bp and 203 bp while the wild type allele
showed a fragment of 590 bp. Fourteen members of the family
(seven  affected  members  and  seven  unaffected  members)
were  analyzed  by  restriction  enzyme  digestion.  This
polymorphism was observed in the heterozygous state in five
affected members, and it was not detected in the unaffected
individuals.  Digestion  analysis  of  50  healthy  unrelated
individuals also did not detect the substitution.
DISCUSSION
The transparency and high refractive index of the lens are
achieved by the precise architecture of the fiber cells and the
homeostasis  of  the  lens  proteins  in  terms  of  their
concentration, stability, and supramolecular organization [6].
Pras  et  al.  [37]  estimated  that  approximately  30  loci  are
involved in autosomal dominant human congenital cataract.
Different crystallin genes have been recognized as the main
candidates  for  certain  hereditary  forms  of  lens  opacity  in
humans [12].
In this study, we identified a mutation in the first exon of
CRYAA (R12C) in Family 4. The affected family members
presented  with  nuclear  cataract  and  had  no  other  ocular
defects. Since this mutation segregates with the disease within
this  family  and  could  not  be  detected  in  50  controls,  we
consider this allele as the probable causative molecular lesion
for  the  observed  clinical  findings.  The  abnormal  protein
produced for this heterozygous mutation may precipitate in
the lens and therefore induce the precipitation of other proteins
[37].  During  the  course  of  this  study,  the  same  R12C
substitution  was  independently  associated  with  congenital
central, zonular cataract with microcornea in a Danish family
[21]. The difference between the phenotype reported in this
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be related to the effect of an unknown modifier gene or to
sequence variation within the regulatory region that could
affect the expression of CRYAA. Previous studies have already
reported phenotypic heterogeneity of the disease with the
same mutation in CRYAA [38].
The αA-crystallins belong to the small heat shock protein
family and function as chaperones. They all share a common
structure  of  an  NH2-terminal  less-conserved  region,  a
conserved α-crystallin domain, and a short COOH-terminal.
Molecular chaperones facilitate the correct folding of proteins
in  vivo  and  are  of  extreme  importance  in  keeping  these
proteins properly folded and in a functional state [39].
The  R12C  mutation  is  located  in  the  NH2-terminal
portion, and the alignment of the primary sequence for small
heat  shock  proteins  from  plants,  bacteria,  and  mammals,
including  human  CRYAA,  demonstrate  that  the  arginine
residue is highly conserved at this position. The conserved
αA-crystallin domain region may be involved in aggregation
and disaggregation of larger protein complexes whereas the
NH2-terminal and the COOH-terminal regions might play a
role  in  oligomerization  [40].  Astonishingly,  all  dominant
mutations  reported  in  CRYAA  have  the  basic  amino  acid
arginine involved. Thus, this residue probably has a very
important role in maintaining the structural integrity of the
lens [41].
Figure 1. Mutation analysis of CRYAA
in Family 4. A: Pedigree of Family 4
shows the proband, which is indicated
by the arrow. B: Direct sequencing of
the PCR product encompasses exon 1 of
CRYAA  (5′→3′)  of  an  unaffected
individual (I-1). C: Direct sequencing of
the PCR product encompassing exon 1
of  CRYAA  of  an  affected  individual
(II-1)  shows  a  heterozygous  C→T
transition  that  replaced  arginine  by
cysteine at amino acid 12 (R12C). The
mutated sequence is shown in red. D:
The slit-lamp photograph of individual
I-2  shows  a  nuclear  cataract.  E:
Alignment of residues 1–60 of human
(8)  αA-crystallin protein with rat (1),
hamster (2), mouse (3), guinea pig (4),
cow (5), sheep (6), pig (7) is shown. The
R12 residue is marked in red.
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(R12C) on αA-crystallin protein function using PolyPhen,
SIFT, and Align-GVGD computational programs. Chan and
colleagues  [32]  demonstrated  that  the  isolated  predictive
value  of  these  programs  can  be  increased  by  their
combination. These programs predict the possible deleterious
effect of an amino acid variant on the structure and function
of  a  protein  based  on  sequence  homology  and  structural
information.  Significantly,  all  three  different  algorithms
considered the R12C mutation as possibly damaging to the
αA-crystallin protein.
Molecular analysis of CRYGD of the affected members
of Family 10 showed a novel heterozygous nonsense mutation
in  exon  2  (TAC>TAG).  This  mutation  resulted  in  the
substitution of the tyrosine residue 56 by a premature stop
codon (Y56X), resulting in a truncated protein missing 118
amino acids.
An increasing number of mutations in CRYGD have been
described in association with human congenital cataract [41].
Hansen et al. [21] related that the mechanisms through which
protein abnormalities cause loss of lens transparency are still
speculative. These truncated protein products may act by a
dominant  negative  mechanism,  giving  rise  to  the  cataract
phenotypes  in  this  family.  The  γ-crystallin  proteins  are  a
superfamily of proteins that have a Greek Key (GK) motif unit
base  [28].  They  contain  two  domains,  an  NH2-terminal
domain  and  a  COOH-terminal  domain  as  the  core.  Each
domain contains two GK motifs. Each GK motif is composed
of four antiparallel β-strands. The two domains are connected
by a distinct connecting peptide [19]. Based on the crystal
structure  of  human  γD-crystallin,  the  Y56X  substitution
resulted in a complete absence of the COOH-terminal domain,
leading to a major change in structural conformation of the
protein. This hypothesis is further supported by the fact that
γD-crystallins  have  shown  a  strong  tendency  to  maintain
conservation throughout evolution in different species. The
computational programs used in this study are not able to
Figure 2. Mutation analysis of CRYGD
in Family 10. A: Pedigree of Family 10
shows the proband, which is indicated
by the arrow. B: Direct sequencing of
the PCR product encompasses exon 2 of
CRYGD  of  an  unaffected  individual
(I-2). C: Direct sequencing of the PCR
product  encompassing  exon  2  of
CRYGD  shows  a  heterozygous
TAC>TAG  transition  that  replaced  a
tyrosine by a premature stop codon at
amino acid 56 (Y56X) in individual II-1.
D: The photograph of the anterior eye
with lens image of individual II-1 shows
nuclear cataract. E: Multiple alignment
of amino acid sequence of γD-crystallin
protein with different species is shown:
mouse (1), rat (2), human (3), cow (4),
and kangaroo (5). The Y56 residue is
marked in red.
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They only apply to missense mutations.
A  new  polymorphism  in  the  third  exon  of  CRYGC
(S119S) was observed in Family 1. It was present in five of
the seven affected individuals and absent in all unaffected
individuals as well as in the control group. We might consider
that  it  represents  a  rare  polymorphism  or  that  it  may  be
exclusive  of  this  sample  of  Brazilian  patients.  Another
hypothesis is that this polymorphism could be a marker of an
unidentified gene located in this region and that its absence in
two of the affected individuals would be due to recombination
events. This fact would make this four-generation family a
target to the analysis of microsatellite markers surrounding
the location of the polymorphism.
In  conclusion,  we  report  a  novel  nonsense  mutation
(Y56X)  in  CRYGD  and  a  previously  reported  missense
mutation (R12C) in CRYAA associated with nuclear cataract
in Brazilian families. Additionally, we also observed a new
polymorphism  (S119S)  in  CRYGC.  The  analysis  of  the
remaining  nine  families  reported  here  excluded  possible
mutations in CRYAA, CRYGC, and CRYGD, suggesting that
other genes/loci could be involved with congenital nuclear/
lamellar cataract.
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